polyclonal asic2 antibody (Alomone Labs)
Structured Review

Polyclonal Asic2 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal asic2 antibody/product/Alomone Labs
Average 93 stars, based on 31 article reviews
Images
1) Product Images from "Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration"
Article Title: Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration
Journal: Cell Death and Differentiation
doi: 10.1038/cdd.2012.158
Figure Legend Snippet: Expression of asic1, asic2 and asic3 during ALS disease progression. (a) Co-staining of lumbar spinal cords from tg SOD1- and asic1a-deficient mice with anti-ASIC1/ASIC2 (red) and anti-NeuN/GFAP (green) antibodies. Arrowheads show co-localization of ASIC1 and ASIC2 with NeuN on cell soma of neurons with motoneuron morphology. Scale bar=20 μm. (b) asic1, −2 and −3 mRNA expression in the transgenic (tg) SOD1 mouse; lumbar spinal cord lysates show a significant upregulation of the asic1a and asic2a mRNA; *P<0.01. Data displayed as mean±S.D.; n=6/group. (c) Co-staining of lumbar spinal cords across disease progression in the tg SOD1 mouse with anti-ASIC1/ASIC2 (red) and anti-NeuN/smi-32 (green) antibodies. Co-localization of ASIC antibodies with motoneurons is indicated by arrowheads. Scale bar=15 μm. (d) An increase in ASIC1 and ASIC2 protein levels in the tg SOD1 mouse; *P<0.01. Data displayed as mean±S.D.; n=6/group. (e) A representative image of ASIC1 and ASIC2 protein (double band) levels by western blotting, n=3 experiments with tubulin as loading control. (f) ASIC2 immunohistochemistry in ventral motoneurons of lumbar spinal cord sections from ALS and non-ALS patients. n=3/group. Scale bar=50 μm
Techniques Used: Expressing, Staining, Transgenic Assay, Western Blot, Immunohistochemistry
Figure Legend Snippet: (A) Characteristics of cases and controls used from ALS and non-ALS patients. (B) Mean staining intensity values for ASIC2 protein in ALS and non-ALS patients
Techniques Used: Staining
